Hint mode is switched on Switch off

Larimar Therapeutics, ordinary share
LRMR, US5171251003

Add a stock to WL
Choose all Reset all
Larimar Therapeutics, сountry — USA
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Analysts forecasts

  • median ***
  • average ***
  • min ***
  • max ***

Issuer

Profile
Larimar Therapeutics Inc operates as a biotech company. The Company develops and discovers treatments for complex rare diseases such as protein replacement therapy. Larimar Therapeutics serves customers in the State of Pennsylvania.
  • Issuer
  • Full borrower / issuer name
    Larimar Therapeutics Inc
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    LRMR
  • Placement
    14.09.2022
  • Lock up period
    180
  • Number of papers
    22,225,000
  • Volume of raised funds
    70.01 mln USD
  • Placement share
    55.65%
  • Final placement price
    3.15 USD
  • Price change since placement date
    22.7%
  • By capitalization
    125.8 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    LRMR
  • Placement
    14.02.2024
  • Lock up period
    180
  • Number of papers
    61,068,375
  • Volume of raised funds
    150 mln USD
  • Placement share
    28.1%
  • Final placement price
    8.74 USD
  • Price change since placement date
    -55.78%
  • By capitalization
    533.74 mln USD
  • Placement type
    SPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    LRMR
  • Placement
    31.07.2025
  • Lock up period
    180
  • Number of papers
    18,750,000
  • Volume of raised funds
    60 mln USD
  • Placement share
    22.65%
  • Final placement price
    3.2 USD
  • Price change since placement date
    20.78%
  • By capitalization
    264.89 mln USD
Other placements of the issuer Hide

IFRS/US GAAP reports

2026
I q eng
2025
I q eng
II q eng
III q eng
IV q eng
2024
I q eng
II q eng
III q eng
IV q eng
2023
I q eng
II q eng
III q eng
IV q eng
2022
I q eng
II q eng
III q eng
IV q eng
2021
I q eng
II q eng
III q eng
IV q eng
2020
I q eng
II q eng
III q eng
IV q eng
2019
I q eng
II q eng
III q eng
IV q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
I q eng
II q eng
III q eng
IV q eng
2016
I q eng
II q eng
III q eng
IV q eng
2015
I q eng
II q eng
III q eng
IV q eng
2014
IV q eng
Show all Hide

Related Stock indices

Indicators

News

16/12/2025 Larimar Therapeutics: Unregistered Sales Of Equity Securities, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Financial Statements And Exhibits
29/07/2025 Larimar Therapeutics: Results Of Operations And Financial Condition
29/07/2025 Larimar Therapeutics: Entry Into A Material Definitive Agreement, Financial Statements And Exhibits
13/05/2025 Larimar Therapeutics: Submission Of Matters To A Vote Of Security Holders
05/05/2025 Larimar Therapeutics: Other Events, Financial Statements And Exhibits
All organization news

Holders

Industry Leaders

Registration is required to get access.